These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7518121)

  • 21. Expression of human decay accelerating factor in transgenic pigs.
    Cozzi E; Langford GA; Richards A; Elsome K; Lancaster R; Chen P; Yannoutsos N; White DJ
    Transplant Proc; 1994 Jun; 26(3):1402-3. PubMed ID: 7518135
    [No Abstract]   [Full Text] [Related]  

  • 22. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of combined expression of human complement regulatory proteins and H-transferase on the inhibition of complement-mediated cytolysis in porcine embryonic fibroblasts.
    Lee JH; Lee HJ; Nahm KM; Jeon HY; Hwang WS; Paik NW; Rho HM
    Transplant Proc; 2006 Jun; 38(5):1618-21. PubMed ID: 16797369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the complement regulatory function of CD59 by site-directed mutagenesis at the N-glycosylation site.
    Akami T; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Nakai I; Mitsuo M; Sawada R; Naruto M; Oka T
    Transplant Proc; 1994 Jun; 26(3):1256-8. PubMed ID: 7518124
    [No Abstract]   [Full Text] [Related]  

  • 25. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
    Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
    Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
    [No Abstract]   [Full Text] [Related]  

  • 27. Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Melli C; Bruzzone P; Alfani D
    Transplant Proc; 1996 Apr; 28(2):589. PubMed ID: 8623287
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro and in vivo studies to prevent hyperacute rejection.
    Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
    Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
    [No Abstract]   [Full Text] [Related]  

  • 29. High-level tissue specific expression of human CD59, MCP, and DAF proteins from genomic clones in transgenic mice.
    Oldham ER; Velardo MA; Platt JL; Logan JS; Diamond L
    Transplant Proc; 1996 Apr; 28(2):693. PubMed ID: 8623349
    [No Abstract]   [Full Text] [Related]  

  • 30. Diminished expression of cell-surface complement regulatory proteins in HIV-infected children and with HIV infection of peripheral blood mononuclear cells in vitro.
    Jarvis JN; Taylor H; Long PM; Gutta PV; Pousak T; Fine N
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):249-56. PubMed ID: 7540489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of double-expression retroviral vector using complement regulatory factor gene.
    Hayashi S; Emi N; Okada H; Yokoyama I; Takagi H
    J Surg Res; 1998 Jul; 78(1):64-7. PubMed ID: 9733620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.
    Uesu T; Mizuno M; Inoue H; Tomoda J; Tsuji T
    Lab Invest; 1995 May; 72(5):587-91. PubMed ID: 7538183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of pigs transgenic for human regulators of complement activation.
    Yannoutsos N; Langford GA; Cozzi E; Lancaster R; Elsome K; Chen P; White DJ
    Transplant Proc; 1995 Feb; 27(1):324-5. PubMed ID: 7533399
    [No Abstract]   [Full Text] [Related]  

  • 34. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoprotective effect of CD59 antigen on xenotransplantation immunity.
    Akami T; Sawada R; Minato N; Naruto M; Yamada A; Imanishi J; Mitsuo M; Nakai I; Okamoto M; Nakajima H
    Transplant Proc; 1992 Apr; 24(2):485-7. PubMed ID: 1373542
    [No Abstract]   [Full Text] [Related]  

  • 36. Production of pigs transgenic for human decay accelerating factor.
    Langford GA; Yannoutsos N; Cozzi E; Lancaster R; Elsome K; Chen P; Richards A; White DJ
    Transplant Proc; 1994 Jun; 26(3):1400-1. PubMed ID: 7518134
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
    Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
    Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
    Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
    Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of human DAF expression in the tissues of transgenic pigs and man.
    Cozzi E; Langford GA; Wright L; Tucker A; Yannoutsos N; Richards A; Rosengard A; Elsome K; Lancaster R; White DJ
    Transplant Proc; 1995 Feb; 27(1):319-20. PubMed ID: 7533397
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29.
    Bjørge L; Jensen TS; Ulvestad E; Vedeler CA; Matre R
    Scand J Immunol; 1995 Apr; 41(4):350-6. PubMed ID: 7534941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.